This book provides a survey of recent advances in the development of antibiofilm agents for clinical and environmental applications. The fact that microbes exist in structured communities called biofilms has slowly become accepted within the medical community. We now know that over 80% of all infectious diseases are biofilm-related; however, significant challenges still lie in our ability to diagnose and treat these extremely recalcitrant infections.
Written by experts from around the globe, this book offers a valuable resource for medical professionals seeking to treat biofilm-related disease, academic and industry researchers interested in drug discovery and instructors who teach courses on microbial pathogenesis and medical microbiology.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
This book provides a survey of recent advances in the development of antibiofilm agents for clinical and environmental applications. The fact that microbes exist in structured communities called biofilms has slowly become accepted within the medical community. We now know that over 80% of all infectious diseases are biofilm-related; however, significant challenges still lie in our ability to diagnose and treat these extremely recalcitrant infections.
Written by experts from around the globe, this book offers a valuable resource for medical professionals seeking to treat biofilm-related disease, academic and industry researchers interested in drug discovery and instructors who teach courses on microbial pathogenesis and medical microbiology.
Imprint | Springer-Verlag |
Country of origin | Germany |
Series | Springer Series on Biofilms, 8 |
Release date | May 2014 |
Availability | Expected to ship within 12 - 17 working days |
First published | 2014 |
Editors | Kendra P. Rumbaugh, Iqbal Ahmad |
Dimensions | 235 x 155 x 32mm (L x W x T) |
Format | Hardcover |
Pages | 497 |
Edition | 2014 |
ISBN-13 | 978-3-642-53832-2 |
Barcode | 9783642538322 |
Categories | |
LSN | 3-642-53832-0 |